Company / Net Income
Eton Pharmaceuticals, Inc. Net Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$936.0K
FY2025
5-year range
-$28.0M / -$936.0K
FY2021-FY2025
Trend
+89.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has fluctuated over the past 7 years, ranging from -$28M in FY2022 to -$936,000 in FY2025.
Based on SEC 10-K filings.
-$936,000 in FY2025.
Improved from -$2M to -$936,000 over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 89.6% year-over-year.
- Lowest net income in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$936.0K | +89.6% |
| FY2024 | -$9.0M | -361.4% |
| FY2023 | -$2.0M | +93.0% |
| FY2022 | -$28.0M | -52.7% |
| FY2021 | -$18.3M | -43.8% |
| FY2020 | -$12.7M | -78.0% |
| FY2019 | -$7.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026